Lupin, Indiaâ€™s fourth largest drugmaker by sales, will acquire US-based Gavis Pharmaceuticals for $880 million (Rs 5,610 crore). The acquisition, the largest by an Indian pharma firm in the US, will help Lupin increase its presence in the US market. Lupin said that the acquisition will give it access to 66 generic drugs. 